SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US OTC > Biotechs >

U.S. Stem Cell Inc. (USRM)

Add USRM Price Alert      Hide Sticky   Hide Intro
Moderator: TheHungryHippo, Papa Bear, BluSkies, StaleyCornell, buythebuy, mtlebomac
Search This Board: 
Last Post: 5/22/2017 5:07:53 PM - Followers: 860 - Board type: Free - Posts Today: 445



Bioheart, Inc. is committed to the discovery and development of autologous cellular therapies to treat a variety of degenerative diseases, as well as the continuation of our ongoing research for the treatment of heart failure, cardiovascular and perioheral vascular disease. 


The US. Stem Cell Inc. Vision
Our vision is to improve the quality of patients’ lives, while reducing hospitalizations and healthcare costs. 
Bioheart is and will continue to be recognized by physicians and patients as the world’s leader in providing 
innovative treatment and management of patients with severe cardiovascular and peripheral vascular 
disease.We are also focused on the discovery, development and commercialization of autologous cell therapies 
for the treatment of degenerative diseases.




Mike Tomás

President & CEO

Mike Tomas. Mr. Mike Tomas was appointed President and Chief Executive Officer and a member of our Board of Directors on June 19, 2010. Mike Tomas was appointed as the Company’s President and Chief Executive Officer, and as a director on June 19, 2010. Mr. Tomas has been President for the past nine years of The ASTRI Group, an early stage private equity investment company in Florida with an investment in Bioheart since 2001. In 2003, he joined Bioheart’s Board of Directors as the independent representative of The ASTRI Group. ASTRI provides capital, business development and strategic marketing support to emerging private companies. Mr. Tomas will continue to serve as President of The ASTRI Group. Previously from 1983 to 2001, Mr. Tomas held ascending executive positions including Chief Marketing Officer at Avantel, a $1 billion dollar joint venture with MCI. Upon retiring from MCI and WorldCom, Tomas joined other ex-MCI executives and helped raise $40M in venture capital to form Ineto, an integrated customer communications software solution that was successfully sold in 2001.
Mr. Tomas sits on the boards of Avisena (revenue cycle management company for medical practices), SilverSky (fka Perimeter Internetworking) (SaaS/managed security services provider for medical practices and financial institutions), Rokk3r Labs (a digital and mobile products developer and portfolio), Bioheart (adult stem cell development for heart muscle tissue repair) and is the current chairman of Florida International University’s Global Entrepreneurship Center. He is an inductee into the Miami-Dade College and WACE Halls of Fame for business, an FIU Torch Award winner — and winner of top communications, medical innovations, education and entrepreneurial awards. Mr. Tomas holds a Masters of Business Administration from the University of Miami and a Bachelor’s degree from Florida International University.

Kristin Comella

Chief Scientific Officer

Kristin Comella. Ms. Comella was appointed Chief Scientific Officer in September 2010. Ms. Comella has served as our Vice President of R&D and Corporate Development since December 2008 and has played a major role in managing our product development, manufacturing and quality systems since joining Bioheart in 2004. Ms. Comella has 15 years of industry experience with expertise in regenerative medicine, training and education, research and product development, and currently serves on multiple advisory boards in the stem cell arena. Ms. Comella has many years of cell culturing experience including building and managing the stem cell laboratory at Tulane University's Center for Gene Therapy and developing stem cell therapies for osteoarthritis at Osiris Therapeutics. Ms. Comella holds an M.S. in Chemical Engineering from The Ohio State University and a B.S. in Chemical Engineering from the University of South Florida.  On March 12, 2013, Kristin Comella was appointed to serve as a member of our Board of Directors.

Dr. William P. Murphy, Jr.

William P. Murphy, Jr., M.D. Dr. Murphy has served as a member of our Board of Directors since June 2003. Dr. Murphy founded Small Parts, Inc., a supplier of high quality mechanical components for design engineers, in 1964 and served as its Chairman until his retirement in April 2005. Small Parts, Inc. was acquired by, Inc. in March 2005. From October 1999 until October 2004, Dr. Murphy served as the Chairman and Chief Executive Officer of Hyperion, Inc., a medical diagnosis company which had an involuntary bankruptcy filed against it in December 2003. Dr. Murphy is the founder of Cordis Corporation (now Cordis Johnson & Johnson) which he led as President, Chairman and Chief Executive Officer at various times during his 28 years at Cordis until his retirement in October 1985. Cordis Johnson & Johnson is a leading firm in cardiovascular instrumentation. Dr. Murphy received an M.D. in 1947 from the University of Illinois and a B.S in pre-medicine from Harvard College in 1946. He also studied physiologic instrumentation at Massachusetts Institute of Technology, or MIT. After a two year rotating internship at St. Francis Hospital in Honolulu, he became a Research Fellow in Medicine at the Peter Bent Brigham Hospital in Boston where he was the dialysis engineer on the first clinical dialysis team in the United States. He continued as an Instructor in Medicine and then a research associate in Medicine at Harvard Medical School. Dr. Murphy is the author of numerous papers and owns 17 patents. He is the recipient of a number of honors, including the prestigious Lemelson-MIT Lifetime Achievement Award, the MIT Corporate Leadership Award, the Distinguished Service Award from North American Society of Pacing and Electrophysiology, and the Jay Malina Award from the Beacon Council of Miami, Florida. He is also a member of the Inventors Hall of Fame


Executive Officers and Directors

Set forth below is information regarding our executive officers and directors as of December 31, 2013

Mike Tomas 48 Director, President and Chief Executive Officer, Chief Financial Officer
William P. Murphy, Jr., M.D. 90 Director, Chairman of the Board
Mark P. Borman  59  Director
Charles A. Hart  53 Director
Sam Ahn  59 Director
Kristen Comella  37 Director, Chief Scientific Officer
Sheldon T. Anderson 63 Director


Business Strategy

 Our principal objective is to become a leading regenerative medicine company that discovers, develops and commercializes novel, autologous cell therapies, and related devices, for the treatment and improved care of patients suffering from chronic and acute heart damage as well as lower limb ischemia. Our secondary objective is the discovery, development and commercialization of autologous cell therapies for the treatment of degenerative diseases.  The number of heart failure patients is expected to increase from 25 million worldwide today to over 50 million in five years. Our focus is on serving these patients. To achieve our primary objective, we plan to pursue the following strategies:

  • - Obtain initial regulatory approval of MyoCell and/or MyoCell SDF-1 by targeting patients with severe heart damage. 
    - Continue existing studies with adipose derived stem cells and endothelial progenitor cells.
    - Continue to develop our pipeline of cell-based therapies and related devices for the treatment of chronic and acute heart damage. 
    - Develop our sales and marketing capabilities. 
    - Continue to refine our MyoCell and MyoCell SDF-1 cell culturing processes.
    - Expand and enhance our intellectual property rights.
    - License, acquire and/or develop complementary products and technologies. 

USRM - Daily Candlesticks


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
USRM News: Quarterly Report (10-q) 05/02/2017 04:06:21 PM
USRM News: Significant Updates on the Following Companies and New Coverage 04/20/2017 09:00:00 AM
USRM News: Grey Cloak Tech, Inc. (OTC Pink: GRCK), Acquires $6.4mm ShareRails, Inc. – $1.7 million in Sales, 300% Growth 04/12/2017 08:49:04 AM
USRM News: Grey Cloak Tech, Inc. (OTC Pink: GRCK), Acquires $6.4mm ShareRails, Inc. – $1.7 million in Sales, 300% Growth 04/12/2017 08:47:59 AM
USRM News: Statement of Changes in Beneficial Ownership (4) 03/31/2017 04:02:24 PM
#59623  Sticky Note TOP TEN REASONS I'M LONG ON $USRM RIGHT NOW. TheHungryHippo 05/13/17 01:34:26 AM
#52397  Sticky Note This is the guy who is investing up Vita Nova Stocks 04/15/17 09:22:22 AM
#42457  Sticky Note THIS IS A MUST READ slam4202 03/30/17 07:05:37 AM
#26891  Sticky Note $USRM ALL IN ONE DD Post for Investors: TheHungryHippo 03/09/17 05:25:50 AM
#26168  Sticky Note Thoughts? BluSkies 03/07/17 09:49:57 PM
#62634   The term buyout usually refers to one company Lonewolf1 05/22/17 05:13:31 PM
#62633   PPS? Newlife2017 05/22/17 05:10:41 PM
#62632   PPS could skyrocket Zboricua 05/22/17 05:10:00 PM
#62631   What exactly happens to the stock when there drmoney1 05/22/17 05:07:53 PM
#62630   Oooooh what did i say at lunchtime? That pennystocKING13 05/22/17 05:07:32 PM
#62629   LOL, reason? End of month speculation that is all. marina22 05/22/17 05:06:25 PM
#62628   About 2 months ago in a court document, NoMoDo 05/22/17 05:04:49 PM
#62627   There will be no mistaking that "a buy blackmuddy0523 05/22/17 05:03:52 PM
#62626   Yah sure marina22 05/22/17 05:03:12 PM
#62625   I know news is coming soon and I Chico Byrd 05/22/17 05:02:43 PM
#62624   Thankyou so much Blackmuddy , I do appreciate Newlife2017 05/22/17 04:57:11 PM
#62623   That was a very good guess! That is blackmuddy0523 05/22/17 04:55:53 PM
#62622   Give us some news! There's gotta be a Ryguy008 05/22/17 04:55:08 PM
#62621   Sooooo STRONGGGG$$$$ TooYoungToDie 05/22/17 04:50:40 PM
#62620   I am thinking about a big company buying Newlife2017 05/22/17 04:49:45 PM
#62619   $$$$$$$$$$$$$$$$$$$$$$$$$$$BUY OUT$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$ blackmuddy0523 05/22/17 04:49:38 PM
#62618   That means we get free puppies !! And OTC_MILLIONAIR 05/22/17 04:47:59 PM
#62617   NewLife 2017.....If you had to give it your blackmuddy0523 05/22/17 04:44:47 PM
#62616   * * $USRM Video Chart 05-22-17 * * ClayTrader 05/22/17 04:41:44 PM
#62615   I agree. Great day today! $USRM #GoLongFTW MyzStreet 05/22/17 04:40:33 PM
#62614   Could anybody explain to me what is a Newlife2017 05/22/17 04:40:31 PM
#62613   NYMike I AGREE!!! I think upon full FDA Cisckid 05/22/17 04:40:06 PM
#62611   Good day today. I prefer slow and steady drmoney1 05/22/17 04:28:22 PM
#62610   It'll get to dollars range on approval. Buyout NYMike1 05/22/17 04:28:09 PM
#62609   Humor yes..sarcasm nope...this thing is about to go afterhoursearnings 05/22/17 04:24:35 PM
#62608   Hint of sarcasm there. I do feel really Callmedragon03 05/22/17 04:21:45 PM
#62607   Short term I predict .20-.50 long term 1-2$ 0mn1 05/22/17 04:19:20 PM
#62605   By end of week. mark this one! shaman919 05/22/17 04:19:16 PM
#62604   Barchart went up to 100% Newlife2017 05/22/17 04:19:09 PM
#62603   Lol we havent even left the ground yet mang afterhoursearnings 05/22/17 04:18:29 PM
#62602   Usrm solid close! nulmer21 05/22/17 04:18:18 PM
#62601   Starts with an S! Swim, Swami, Slippy, Slappy, shaman919 05/22/17 04:17:58 PM
#62600   USRM No way!!!!! this will never even make BoilerRoom 05/22/17 04:17:51 PM
#62599   Does anybody see this stock going at least $1.00? MagicMike08 05/22/17 04:17:51 PM
#62597   Damn a 96% Barchart Brandonworst 05/22/17 04:16:23 PM
#62596   Noooo WAYYY!!!?!?? THATS GREAT!! WE LANDED ON THE MOON!!! Callmedragon03 05/22/17 04:15:39 PM
#62595   I agree. Thanks! It does get kind of old. coachvw 05/22/17 04:15:24 PM
#62594   He is okay. linlinktao 05/22/17 04:14:57 PM
#62592   i am praying for FDA approval!! massivegains10 05/22/17 04:08:21 PM
#62590   WOWZA NEVER SEEN THIS tamtam84 05/22/17 04:04:33 PM
#62589   Great, Great MONDAY... Go #USRM Carlosstock 05/22/17 04:04:03 PM
#62588   No fill today. Will try again tomorrow. zturk 05/22/17 04:02:44 PM
#62587   we got swag today! Ryguy008 05/22/17 04:02:39 PM
#62586   Release the KRAKEN!!! Great close USRM flexin!!!! CaptainObvious2017 05/22/17 04:01:32 PM
#62585   Oh Lord let's see what's gonna happen ! Newlife2017 05/22/17 04:01:13 PM
#62584   Excellent $USRM EOM 11JR11 05/22/17 04:01:00 PM
#62583   One minute guys ! Fasten seat belts ! Newlife2017 05/22/17 03:59:25 PM
#62582   Tmr we break 90 day vol avg...? 10 afterhoursearnings 05/22/17 03:58:49 PM
#62581   Ready to skyrocket, if not am ready to Newlife2017 05/22/17 03:58:43 PM
#62580   RELEASE THE KRAKEN! Come on everyone! Ryguy008 05/22/17 03:58:02 PM